Galcanezumab for the preventive treatment of episodic and chronic migraine in real life: A prospective multicenter study in Colombia and Mexico, including effects on anxiety and depression—on behalf of ASOLAC.

Saved in:
Bibliographic Details
Title: Galcanezumab for the preventive treatment of episodic and chronic migraine in real life: A prospective multicenter study in Colombia and Mexico, including effects on anxiety and depression—on behalf of ASOLAC.
Authors: Muñoz-Cerón, Joe1,2 (AUTHOR) joemunoz@keralty.co, Vélez-Jiménez, Karina3 (AUTHOR), Bohórquez-Valderrama, Stephanía4 (AUTHOR), Rodríguez-Leyva, Ildefonso5 (AUTHOR), Hernández, Natalia6 (AUTHOR), Gallo-Eugenio, Loren2 (AUTHOR), Moreno-Rodríguez, Claudia1 (AUTHOR), Jiménez-Jaramillo, Juan7 (AUTHOR), Guerra-Posada, Carolina8 (AUTHOR), Ramos-Romero, Marta9 (AUTHOR), Bernal-Cobo, Rafael7 (AUTHOR), Rojas-Villegas, Yessica10 (AUTHOR), Cavanzo-Henao, Paula11 (AUTHOR), López-González, Reydmar12 (AUTHOR), Gómez-Barrera, Daniela2 (AUTHOR)
Source: Cephalalgia Reports. 3/2/2026, Vol. 9, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:25158163
DOI:10.1177/25158163261418597